The deal combines Stereotaxis’ magnetic navigation technology and Robocath’s mechanical robotic system, strengthening Stereotaxis’ position in endovascular surgery, said CEO David Fischel.
The deal combines Stereotaxis’ magnetic navigation technology and Robocath’s mechanical robotic system, strengthening Stereotaxis’ position in endovascular surgery, said CEO David Fischel.